Sihuan Pharmaceutical Holdings Group Ltd
Company Profile
Business description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Contact
Zhubang 2000
22nd Floor, Building 4
West Balizhuang, Chaoyang District
Beijing100025
CHNT: +86 1057693700
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,667
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,389.60 | 66.60 | -0.79% |
CAC 40 | 7,770.48 | 176.61 | 2.33% |
DAX 40 | 23,086.65 | 589.67 | 2.62% |
Dow JONES (US) | 41,317.43 | 564.47 | 1.39% |
FTSE 100 | 8,596.35 | 99.55 | 1.17% |
HKSE | 22,504.68 | 385.27 | 1.74% |
NASDAQ | 17,977.73 | 266.99 | 1.51% |
Nikkei 225 | 36,830.69 | 378.39 | 1.04% |
NZX 50 Index | 12,392.08 | 64.19 | 0.52% |
S&P 500 | 5,686.67 | 82.53 | 1.47% |
S&P/ASX 200 | 8,172.80 | 65.20 | -0.79% |
SSE Composite Index | 3,279.03 | 7.62 | -0.23% |